Objectives: Tumor mutation burden (TMB) is an emerging predictive cancer biomarker. Few studies have addressed the prognostic role of TMB in non-small cell lung carcinoma, with conflicting results. Moreover, the association of TMB with different histological subtypes of lung adenocarcinoma has hitherto not been systematically evaluated. Here we studied the prognostic value of TMB and its distribution in different histological subtypes of lung adenocarcinomas in a retrospective cohort using the most recent updated classification guidelines.Materials and methods: 176 surgically resected stage I-IV lung adenocarcinomas were histologically reclassified according to WHO 2015 guidelines. A modified classification subdividing the acinar subtype in...
Introduction. The latest histological classification of lung adenocarcinoma includes lepidic, acinar...
Background:Patients with pathological stage IA adenocarcinoma (AC) have a variable prognosis, even i...
Introduction. The latest histological classification of lung adenocarcinoma includes lepidic, acinar...
Objectives: Tumor mutation burden (TMB) is an emerging predictive cancer biomarker. Few studies have...
IntroductionWe investigated the relationship between predominant subtype, according to the Internati...
The primary objective of this study is to evaluate tumor mutational burden (TMB), its associations w...
BACKGROUND The primary objective of this study is to evaluate tumor mutational burden (TMB), its ...
Introduction: Lung adenocarcinoma is the most common type of lung cancer and typically carries a hig...
Introduction: We investigated the relationship between predominant subtype, according to the Interna...
IntroductionLung adenocarcinoma is a heterogeneous group of tumors with a highly variable prognosis,...
BACKGROUND: The role of tumor mutational burden (TMB) is still debated for selecting advanced non-on...
Background: Predominant histologic subtypes have been reported as predictors of survival of patients...
Aims: The decision to consider adjuvant chemotherapy (AC) for non‐small cell lung cancer is currentl...
Objective: In addition to the most common somatic lung cancer mutations (i. e., KRAS and EGFR mutati...
Introduction:Invasive mucinous adenocarcinoma is a unique histologic subtype of lung cancer, and our...
Introduction. The latest histological classification of lung adenocarcinoma includes lepidic, acinar...
Background:Patients with pathological stage IA adenocarcinoma (AC) have a variable prognosis, even i...
Introduction. The latest histological classification of lung adenocarcinoma includes lepidic, acinar...
Objectives: Tumor mutation burden (TMB) is an emerging predictive cancer biomarker. Few studies have...
IntroductionWe investigated the relationship between predominant subtype, according to the Internati...
The primary objective of this study is to evaluate tumor mutational burden (TMB), its associations w...
BACKGROUND The primary objective of this study is to evaluate tumor mutational burden (TMB), its ...
Introduction: Lung adenocarcinoma is the most common type of lung cancer and typically carries a hig...
Introduction: We investigated the relationship between predominant subtype, according to the Interna...
IntroductionLung adenocarcinoma is a heterogeneous group of tumors with a highly variable prognosis,...
BACKGROUND: The role of tumor mutational burden (TMB) is still debated for selecting advanced non-on...
Background: Predominant histologic subtypes have been reported as predictors of survival of patients...
Aims: The decision to consider adjuvant chemotherapy (AC) for non‐small cell lung cancer is currentl...
Objective: In addition to the most common somatic lung cancer mutations (i. e., KRAS and EGFR mutati...
Introduction:Invasive mucinous adenocarcinoma is a unique histologic subtype of lung cancer, and our...
Introduction. The latest histological classification of lung adenocarcinoma includes lepidic, acinar...
Background:Patients with pathological stage IA adenocarcinoma (AC) have a variable prognosis, even i...
Introduction. The latest histological classification of lung adenocarcinoma includes lepidic, acinar...